Our research projects
Thanks to our supporters we are able to carry out more than £2m worth of ground-breaking research every year in 4 centres across the UK, into the causes of miscarriage, stillbirth and premature birth. Discover our research projects here.
Pre-eclampsia
Kynurenine as a potential treatment for women with pre-eclampsia
Scientists are testing kynurenine in the lab to see if it can be used to treat blood vessel problems that are caused by pre-eclampsia.
Stillbirth research
Is there a better way to test new treatments that could improve how well the placenta is working?
Tommy's researchers are working out the best way to test new therapies that could improve how well the placenta is functioning and so prevent stillbirth.
Stillbirth research
The effects of age on stillbirth
Our researchers want to find out more about why the placentas of older women do not work as well as they should so that we can develop new treatments to help prevent stillbirth.
Pregnancy complication research
Beetroot juice can reduce blood pressure in pregnancy, but why do some people not respond?
Tommy's wants to find out why drinking beetroot juice reduces blood pressure in some pregnant women with hypertension, and not others.
Stillbirth research
The Tommy’s Project: understanding how pregnancy goes wrong
Our researchers are collecting information and tissue samples from thousands of women to better understand the causes of complications that can lead to stillbirth or neonatal death.
Stillbirth research
The INVEST study: Can increased fetal movement be a sign that something is wrong?
Tommy's researchers found no link between a baby moving more than normal for a period of time and worse pregnancy outcomes, including stillbirth.
Stillbirth research
The role of glutamine and glutamate in fetal growth restriction
Tommy's want to find out whether we can improve the way some placentas transfer amino acids glutamine and glutamate to babies to help them grow properly.
Stillbirth research
Inhibiting microRNAs in the placenta to reduce the risk of stillbirth
Tommy's researchers are looking for new treatments for failing placentas so that we can make sure babies grow properly and reduce the risk of stillbirth.
Miscarriage research
MifeMiso: Mifepristone and misoprostol for the medical management of missed miscarriage
Currently NICE recommends the drug misoprostol but without strong evidence. This trial is designed to find the best treatment for missed miscarriage.
Pre-eclampsia
Kynurenine as a potential treatment for women with pre-eclampsia
Scientists are testing kynurenine in the lab to see if it can be used to treat blood vessel problems that are caused by pre-eclampsia.
Stillbirth research
The Tommy’s Project: understanding how pregnancy goes wrong
Our researchers are collecting information and tissue samples from thousands of women to better understand the causes of complications that can lead to stillbirth or neonatal death.
Stillbirth research
The role of glutamine and glutamate in fetal growth restriction
Tommy's want to find out whether we can improve the way some placentas transfer amino acids glutamine and glutamate to babies to help them grow properly.
Stillbirth research
Is there a better way to test new treatments that could improve how well the placenta is working?
Tommy's researchers are working out the best way to test new therapies that could improve how well the placenta is functioning and so prevent stillbirth.
Pregnancy complication research
Beetroot juice can reduce blood pressure in pregnancy, but why do some people not respond?
Tommy's wants to find out why drinking beetroot juice reduces blood pressure in some pregnant women with hypertension, and not others.
Stillbirth research
Inhibiting microRNAs in the placenta to reduce the risk of stillbirth
Tommy's researchers are looking for new treatments for failing placentas so that we can make sure babies grow properly and reduce the risk of stillbirth.
Stillbirth research
The effects of age on stillbirth
Our researchers want to find out more about why the placentas of older women do not work as well as they should so that we can develop new treatments to help prevent stillbirth.
Stillbirth research
The INVEST study: Can increased fetal movement be a sign that something is wrong?
Tommy's researchers found no link between a baby moving more than normal for a period of time and worse pregnancy outcomes, including stillbirth.
Miscarriage research
MifeMiso: Mifepristone and misoprostol for the medical management of missed miscarriage
Currently NICE recommends the drug misoprostol but without strong evidence. This trial is designed to find the best treatment for missed miscarriage.